[Federal Register Volume 85, Number 26 (Friday, February 7, 2020)]
[Notices]
[Pages 7319-7320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02403]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Leveraging Big Data Science to Elucidate the
[[Page 7320]]
Mechanisms of HIV Activity and Interaction with Substance Use
Disorder.
Date: March 5, 2020.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Science Center,
6001 Executive Boulevard, Room 4238, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer,
Office of Extramural Affairs, National Institute on Drug Abuse,
National Institutes of Health, 6001 Executive Boulevard, Room 4238,
MSC 9550, Bethesda, MD 20892, 301-402-6020, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA Core and Research Center of Excellence Grant
Program (P30/50 Clinical Trial Optional).
Date: March 9-10, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard Marriott Bethesda Chevy Chase, 5520 Wisconsin
Avenue, Chevy Chase, MD 20815.
Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, National
Institutes of Health, 6001 Executive Boulevard, Room 4234, Bethesda,
MD 20892, 301-402-7371, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIH Pathway to Independence Award (K99/R00).
Date: March 19, 2020.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Science Center,
6001 Executive Boulevard, Room 4229, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Susan O. McGuire, Ph.D., Scientific Review
Officer, Office of Extramural Affairs, National Institute on Drug
Abuse, National Institutes of Health, 6001 Executive Boulevard, Room
4245, Rockville, MD 20852, 301-435-1426, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Alcohol and Other Substance Use Research Education
Programs for Health Professionals (R25 Clinical Trial Not Allowed).
Date: April 6, 2020.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Science Center,
6001 Executive Boulevard, Room 4229, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Susan O. McGuire, Ph.D., Scientific Review
Officer Office, of Extramural Affairs, National Institute on Drug
Abuse, National Institutes of Health, 6001 Executive Boulevard, Room
4245, Rockville, MD 20852, 301-435-1426, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: February 3, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-02403 Filed 2-6-20; 8:45 am]
BILLING CODE 4140-01-P